Eli Lilly: The True Frontier Of Real-World AI Monetization (NYSE:LLY)
· seekingalpha.com
Eli Lilly and Company is a top AI-driven drug discovery stock, with strong earnings growth, new market potential, and near-term upside. Learn more about LLY stock here.
As far as I understand, investors are already tired of promises around yet another wave of chatbots and picture generation. The market needs an understandable c...